Bellus shareholders approve US$2-billion takeover by GSK; deal set to close this month
The US$14.75-a-share deal, which goes to the Quebec Superior Court next week for approval, is the latest in a series of US$1-billion-plus takeovers of Canadian life sciences companies
Source: theglobeandmail.com